These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25448571)

  • 1. Reduction of glycine particle size by impinging jet crystallization.
    Tari T; Fekete Z; Szabó-Révész P; Aigner Z
    Int J Pharm; 2015 Jan; 478(1):96-102. PubMed ID: 25448571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of crystallization processes in case of glycine crystallization].
    Aigner Z; Szegedi A; Szabadi V; Ambrus R; Sovány T; Szabóné Révész P
    Acta Pharm Hung; 2012; 82(2):61-8. PubMed ID: 22870778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of salmeterol xinafoate microparticle production by conventional and novel antisolvent crystallization.
    Murnane D; Marriott C; Martin GP
    Eur J Pharm Biopharm; 2008 May; 69(1):94-105. PubMed ID: 17981448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
    Cho E; Cho W; Cha KH; Park J; Kim MS; Kim JS; Park HJ; Hwang SJ
    Int J Pharm; 2010 Aug; 396(1-2):91-8. PubMed ID: 20558265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of nicergoline polymorphs crystallized in several organic solvents.
    Malaj L; Censi R; Capsoni D; Pellegrino L; Bini M; Ferrari S; Gobetto R; Massarotti V; Di Martino P
    J Pharm Sci; 2011 Jul; 100(7):2610-22. PubMed ID: 21254066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Theory and practice of electrospray crystallization in particle size reduction].
    Szunyogh T; Ambrus R; Szabóné Révész P
    Acta Pharm Hung; 2015; 85(2):43-50. PubMed ID: 26390735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods.
    Li Y; Yang DJ; Chen SL; Chen SB; Chan AS
    Pharm Res; 2008 Mar; 25(3):563-77. PubMed ID: 17828444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hollow crystalline straws of diclofenac for high-dose and carrier-free dry powder inhaler formulations.
    Yazdi AK; Smyth HD
    Int J Pharm; 2016 Apr; 502(1-2):170-80. PubMed ID: 26911418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of crystal habit on the dissolution behaviour of simvastatin crystals and its relationship to crystallization solvent properties.
    Bukovec P; Benkic P; Smrkolj M; Vrecer F
    Pharmazie; 2016 May; 71(5):263-8. PubMed ID: 27348970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolution enhancement of Deflazacort using hollow crystals prepared by antisolvent crystallization process.
    Paulino AS; Rauber G; Campos CE; Maurício MH; de Avillez RR; Capobianco G; Cardoso SG; Cuffini SL
    Eur J Pharm Sci; 2013 May; 49(2):294-301. PubMed ID: 23557843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology.
    Padrela L; Rodrigues MA; Velaga SP; Matos HA; de Azevedo EG
    Eur J Pharm Sci; 2009 Aug; 38(1):9-17. PubMed ID: 19477273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of pH and method of crystallization on the solid physical form of indomethacin.
    Dubbini A; Censi R; Martena V; Hoti E; Ricciutelli M; Malaj L; Di Martino P
    Int J Pharm; 2014 Oct; 473(1-2):536-44. PubMed ID: 25064728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of submicron-sized niflumic acid crystals prepared by electrospray crystallization.
    Ambrus R; Radacsi N; Szunyogh T; van der Heijden AE; Ter Horst JH; Szabó-Révész P
    J Pharm Biomed Anal; 2013 Mar; 76():1-7. PubMed ID: 23287488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro dissolution enhancement of micronized l-nimodipine by antisolvent re-crystallization from its crystal form H.
    Zu Y; Li N; Zhao X; Li Y; Ge Y; Wang W; Wang K; Liu Y
    Int J Pharm; 2014 Apr; 464(1-2):1-9. PubMed ID: 24456674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisolvent precipitation technique: A very promising approach to crystallize curcumin in presence of polyvinyl pyrrolidon for solubility and dissolution enhancement.
    Sadeghi F; Ashofteh M; Homayouni A; Abbaspour M; Nokhodchi A; Garekani HA
    Colloids Surf B Biointerfaces; 2016 Nov; 147():258-264. PubMed ID: 27518458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of crystallisation conditions and feedstock morphology on the aerosolization performance of micronised salbutamol sulphate.
    Shariare MH; de Matas M; York P
    Int J Pharm; 2011 Aug; 415(1-2):62-72. PubMed ID: 21683128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphic control of inhalation microparticles prepared by crystallization.
    Murnane D; Marriott C; Martin GP
    Int J Pharm; 2008 Sep; 361(1-2):141-9. PubMed ID: 18582548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal doping aided by rapid expansion of supercritical solutions.
    Vemavarapu C; Mollan MJ; Needham TE
    AAPS PharmSciTech; 2002; 3(4):E29. PubMed ID: 12916923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing an environmentally benign process for the production of microparticles: amphiphilic crystallization.
    Murnane D; Marriott C; Martin GP
    Eur J Pharm Biopharm; 2008 May; 69(1):72-82. PubMed ID: 18082385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-line monitoring and interpretation of an indomethacin anti-solvent crystallization process by near-infrared spectroscopy (NIRS).
    Lee HE; Lee MJ; Kim WS; Jeong MY; Cho YS; Choi GJ
    Int J Pharm; 2011 Nov; 420(2):274-81. PubMed ID: 21907779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.